未登录

R

Ruiqing Ma

aerospace central hospital

H指数:9

被引数:202

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The impact of anemia within 24 h after surgery on the prognosis of patients with pseudomyxoma peritonei

术后24小时内贫血对腹膜假粘液瘤患者预后的影响

Frontiers in Oncology

IF3.3

2025-11-180

OAAI

Prophylactic oophorectomy is recommended in female patients with pseudomyxoma peritonei of an appendiceal origin

预防性卵巢切除术建议用于阑尾来源的腹膜黏液瘤女性患者

Frontiers in Oncology

IF3.3

2025-07-270

OA

Pseudomyxoma peritonei originating from small intestine: A case report and review of literature

小肠来源的腹膜假黏液瘤：病例报告及文献综述

WORLD JOURNAL OF CLINICAL ONCOLOGY

IF3.2

2025-04-240

PRE

Prognosis conferred by molecular features of appendix-derived Pseudomyxoma Peritonei

腹膜假黏液瘤（Pseudomyxoma Peritonei）的分子特征所提示的预后

TRANSLATIONAL ONCOLOGY

IF4.1

2025-03-010

PRE

Prediction of preoperative peritoneal cancer index for pseudomyxoma peritonei by multiple linear regression analysis

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2024-12-230

OAAI

Anesthesia management of CRS and HIPEC in advanced ovarian cancer with ultra-high intra-abdominal pressure: a case report

FRONTIERS IN ONCOLOGY

IF3.3

2024-11-270

OAAI

Comparison of functional characterization of cancer stem cells in different tumor tissues of pseudomyxoma peritonei

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2024-11-140

OAAI

Global trends in research of pseudomyxoma peritonei: a bibliometric and visualization analysis

FRONTIERS IN ONCOLOGY

IF3.3

2024-02-084

OAAI

Hyperthermic intraperitoneal chemotherapy in patients with incomplete cytoreduction for appendiceal pseudomyxoma peritonei: a 10-year treatment experience in China

ORPHANET JOURNAL OF RARE DISEASES

IF3.5

2024-01-041

OAAI

Bland-Altman agreement analysis between CT predicted and surgical peritoneal cancer index in pseudomyxoma peritonei of appendiceal origin

SCIENTIFIC REPORTS

IF3.9

2023-12-063

OAAI

Whole-Exome Sequencing Identifies Mutation Profile and Mutation Signature-Based Clustering Associated with Prognosis in Appendiceal Pseudomyxoma Peritonei

MOLECULAR CANCER RESEARCH

IF4.7

2023-09-282

PRE

Combination therapy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent leiomyomatosis peritonealis disseminata with endometriosis: A case report

IF3.6

2023-09-013

OAAI

Significance of laparoscopic cytoreductive surgery for appendiceal pseudomyxoma peritonei with limited disease and low tumor burden

ASIAN JOURNAL OF SURGERY

IF3.8

2023-03-013

OAAI

Serum and ascites tumor markers in the diagnostic and prognostic prediction for appendiceal pseudomyxoma peritonei

IF3.4

2023-01-263

OAAI

Case Report: Stage IIIc primary malignant mixed Mullerian tumor of the fallopian tube: A case of 5-year disease-free survival after cytoreductive surgery combined with peritoneal resection and adjuvant chemotherapy with paclitaxel plus carboplatin

FRONTIERS IN ONCOLOGY

IF3.3

2022-12-221

OAAI

Transfusion of stored autologous blood in patients with low-grade pseudomyxoma peritonei: A retrospective analysis of its safety and outcome

FRONTIERS IN ONCOLOGY

IF3.3

2022-10-062

OAAI

Prognostic prediction of preoperative nutritional status in low-grade appendiceal mucinous neoplasms

SCIENTIFIC REPORTS

IF3.9

2022-06-231

OAAI

Radiomics analysis based on CT's greater omental caking for predicting pathological grading of pseudomyxoma peritonei

SCIENTIFIC REPORTS

IF3.9

2022-03-152

OAAI

Significance of the Entire Appendiceal Evaluation in the Diagnosis of Serrated Lesions, Low-Grade Appendiceal Mucinous Neoplasm, and Appendiceal Diverticulosis Disease

FRONTIERS IN ONCOLOGY

IF3.3

2022-01-185

OAAI

Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei

FRONTIERS IN ONCOLOGY

IF3.3

2021-10-1815

OAAI